Literature DB >> 14189715

PHOSPHOLINE IODIDE (217M1) (ECOTHIOPHATE IODIDE) IN THE TREATMENT OF GLAUCOMA.

J P LLOYD.   

Abstract

Entities:  

Keywords:  ACETAZOLAMIDE; DRUG THERAPY; ECHOTHIOPHATE IODIDE; GLAUCOMA; ISOFLUROPHATE; MIOTICS; PHYSOSTIGMINE; PILOCARPINE; SURGERY, OPERATIVE; TOXICOLOGIC REPORT

Mesh:

Substances:

Year:  1963        PMID: 14189715      PMCID: PMC505833          DOI: 10.1136/bjo.47.8.469

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  13 in total

1.  Evaluation and use of oximes in ophthalmology.

Authors:  J G MAMO; I H LEOPOLD
Journal:  Am J Ophthalmol       Date:  1958-11       Impact factor: 5.258

2.  Echothiophate (phospholine) iodide (217-MI) in treatment of glaucoma; further observations.

Authors:  N KRISHNA; I H LEOPOLD
Journal:  AMA Arch Ophthalmol       Date:  1959-08

3.  Antidotes and potentiating agents for phospholine iodide.

Authors:  R A LEHMAN; H M FITCH; L P BLOCHI; H A JEWELL; M E NICHOLLS
Journal:  J Pharmacol Exp Ther       Date:  1960-03       Impact factor: 4.030

4.  Drug antagonism and pAx.

Authors:  H O SCHILD
Journal:  Pharmacol Rev       Date:  1957-06       Impact factor: 25.468

5.  Use of a thiophosphinyl quaternary compound (217-MI) in treatment of glaucoma.

Authors:  I H LEOPOLD; P GOLD; D GOLD
Journal:  AMA Arch Ophthalmol       Date:  1957-09

6.  Differential effects of a quaternary cholinesterase inhibitor, phospholine, and its tertiary analogue, compound 217-AO, on central control of respiration and on neuromuscular transmission: the antagonism by 217-AO of the respiratory arrest caused by morphine.

Authors:  W SCHAUMANN; C JOB
Journal:  J Pharmacol Exp Ther       Date:  1958-06       Impact factor: 4.030

7.  The cerebral distributions of a tertiary and a quaternary anticholinesterase agent following intravenous and intraventricular injection.

Authors:  G B KOELLE; E C STEINER
Journal:  J Pharmacol Exp Ther       Date:  1956-12       Impact factor: 4.030

8.  Antagonism of phospholine (echothiophate) iodide by certain quaternary oximes.

Authors:  R A LEHMAN; M E NICHOLLS
Journal:  Proc Soc Exp Biol Med       Date:  1960 Aug-Sep

9.  Glaucoma therapy with echothiophate (phospholine iodide).

Authors:  A SACKS-WILNER; E SACKS-WILNER
Journal:  Am J Ophthalmol       Date:  1961-04       Impact factor: 5.258

10.  The tonographic effects of echothiophate (phospholine) iodide: reversal by pyridine-2-aldoxine methiodide (P2AM).

Authors:  B BECKER; G C PYLE; R C DREWS
Journal:  Am J Ophthalmol       Date:  1959-05       Impact factor: 5.258

View more
  2 in total

1.  CLINICAL OBSERVATIONS ON THE USE OF PHOSPHOLINE IODIDE IN GLAUCOMA.

Authors:  J ROMANO; H JACKSON
Journal:  Br J Ophthalmol       Date:  1964-09       Impact factor: 4.638

2.  Angle-closure glaucoma precipitated by the use of phospholine iodide for esotropia in a child.

Authors:  D E Jones; D M Watson
Journal:  Br J Ophthalmol       Date:  1967-11       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.